Status:
COMPLETED
Assess Efficacy in Subjects With Traumatic Spinal Cord Injury
Lead Sponsor:
Bayer
Conditions:
Erectile Dysfunction
Spinal Cord Injury
Eligibility:
MALE
18-64 years
Phase:
PHASE4
Brief Summary
Assess efficacy of Vardenafil in patients with traumatic spinal cord injury
Eligibility Criteria
Inclusion
- Men between 18 and 64 years old with stable cord injury (more than 6 months) who had erectile dysfunction according to the National Institutes if Health (NIH) after their traumatic spinal cord injury
Exclusion
- Primary hypoactive sexual desire
- History of myocardial infarction, stroke or life-threatening arrhythmia within prior 6 month
- Nitrate therapy
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2007
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00667966
Start Date
July 1 2005
End Date
February 1 2007
Last Update
May 6 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Badalona, Barcelona, Spain, 08916
2
Toledo, Toledo, Spain, 45071